Related Experiment Video
Updated: Jul 3, 2026

Delivery of Cardioactive Therapeutics in a Porcine Myocardial Infarction Model
Published on: February 10, 2023
[Treatment of malignant pericardial effusion]
Yukio Hosomi1, Yusuke Ohkuma, Masahiko Shibuya
1Division of Pulmonary Medicine, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Bunkyo-ku, Tokyo, Japan.
Abstract:
Cardiac tamponade is an emergency situation that warrants immediate evacuation of the pericardial fluid. Since the fluid tends to recur only by pericardiocentesis, various agents have been instilled into the pericardium to promote adhesion and obliteration of the cavity. Comparative studies of sclerosing agents for the management of malignant pericardial effusion include that comparing the Bleomycin group and non-administered group (JCOG) and another comparing bleomycin and doxycycline in 1996. Both studies recommended Bleomycin to control malignant pericardial effusion. Although instillation of drugs into the pericardium are reportedly safe, paracentesis or tube pericardiostomy are sometimes associated with an incidence of complications, some of which are fatal. These complications are assumed to occur in about 3% of the cases, even if an experienced physician proceeds using an echo guide. Though bleomycin is the recommended drug for the initial sclerosing agent in malignant pericardial effusion, physicians should consider the status and the prognosis of each case in the treatment of malignant pericardial effusion.
More Related Videos
Related Concept Videos
Pericarditis III: Medical Management
Cardiomyopathy V: Interprofessional Care
Pericarditis IV: Nursing Management
Myocarditis III: Medical Management
Cardiomyopathy II: Dilated Cardiomyopathy
Pleural Effusion II: Symptoms and Management
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:

